Teva’s recent Actavis acquisition proves there is strategic power in smart mergers. A thoughtful acquisition that introduces new capabilities and global efficiencies can create the foundation for ...

Actavis was a generics giant whose rise mirrors the huge growth of off-patent medicines, while Gilead has rocketed into pharma's top 20 biggest companies in 2014 thanks to ground and record ...

If you own or are associated with Actavis Pharma Manufacturing Pvt. Ltd. and want to update your company’s information, please click here. Medindia offers the most extensive free access search ...

If you own or are associated with Actavis Pharma Development Centre Pvt. Ltd and want to update your company’s information, please click here. Medindia offers the most extensive free access ...

Teva Pharmaceutical (NYSE ... sclerosis therapy Copaxone and the company's decision to rely heavily on U.S. generics via its $41B buyout of Actavis Generics in 2016. "Upon further reflection ...

The fines were also levied because the two companies persuaded ... (now known as Advanz Pharma) and Waymade to stay out of the market, according to the authority, while Actavis UK continued ...

Actavis CEO Brent Saunders 44, saw the deal through its close in March 2015, at which point he became the CEO of Allergan Plc - now a Dublin-based global pharmaceutical company. In July ...